Mirae Asset Global ETFs Holdings’s Verona Pharma VRNA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,176	Closed	-$659K	–	3175
2025 Q3	$659K	Buy	+6,176	New	+$645K	﹤0.01%	1731

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's VRNA Position: Q4 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 6,176 shares — an estimated $659K sold.

Mirae Asset Global ETFs Holdings first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $659K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Mirae Asset Global ETFs Holdings reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Mirae Asset Global ETFs Holdings sold 6,176 Verona Pharma shares in Q4 2025, an estimated $659K.
Mirae Asset Global ETFs Holdings first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Mirae Asset Global ETFs Holdings's Verona Pharma position peaked at $659K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.